×
Enovis Pre-Tax Income 2010-2025 | ENOV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Enovis pre-tax income from 2010 to 2025. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
View More
Enovis Pre-Tax Income 2010-2025 | ENOV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Enovis pre-tax income from 2010 to 2025. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$46.9B
Hims & Hers Health (HIMS)
$14.7B
Doximity (DOCS)
$11.1B
Tempus AI (TEM)
$10B
IRhythm Technologies (IRTC)
$4.5B
Inspire Medical Systems (INSP)
$3.9B
Hinge Health (HNGE)
$3.5B
Privia Health (PRVA)
$2.4B
10x Genomics (TXG)
$1.7B
Phreesia (PHR)
$1.6B
Azenta (AZTA)
$1.5B
Schrodinger (SDGR)
$1.5B
Clover Health Investments (CLOV)
$1.5B
Omnicell (OMCL)
$1.4B
Evolent Health (EVH)
$1.2B
Claritev (CTEV)
$636M
Fulgent Genetics (FLGT)
$532M
Standard BioTools (LAB)
$524M
Veradigm (MDRX)
$507M
Butterfly Network (BFLY)
$448M
Talkspace (TALK)
$418M
TruBridge (TBRG)
$315M
Outset Medical (OM)
$300M
Health Catalyst (HCAT)
$256M
Nyxoah SA (NYXH)
$243M
SOPHiA GENETICS SA (SOPH)
$212M
CapsoVision (CV)
$190M
Zepp Health (ZEPP)
$175M
KORU Medical Systems (KRMD)
$161M
Pulmonx (LUNG)
$127M